Literature DB >> 3128523

Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.

E E Stobberingh1.   

Abstract

The effect of different concentrations of clavulanic acid (CA) in combination with ticarcillin on beta-lactamase production and ticarcillin MIC was studied in four clinical isolates of Pseudomonas aeruginosa, Enterobacter cloacae, Serratia marcescens, Citrobacter freundii and indole positive Proteus strains. Ticarcillin alone showed a low inducing effect for all species tested, Ser. marcescens excepted. The increase in beta-lactamase activity after addition of CA (2-10 mg/l) was strain and species dependent. No synergy or antagonism was observed on the ticarcillin MIC for the micro-organisms producing only a chromosomally mediated beta-lactamase, though the susceptibility to ticarcillin strongly increased if the strains also produced a plasmid-mediated beta-lactamase. Addition of 50 or 100 mg/l CA resulted in all strains. C. freundii excepted, in a strong increase in beta-lactamase activity and in a strong synergistic effect on the ticarcillin MIC. However, these concentrations are unlikely to be achieved at clinical doses. Thus, irrespective of the inducing effect of ticarcillin and CA (2-10 mg/l) combinations, induction of the chromosomal beta-lactamase did not result in a decrease in ticarcillin susceptibility.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128523     DOI: 10.1093/jac/21.1.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Emergence of resistance to beta-lactam agents in Pseudomonas aeruginosa with group I beta-lactamases in Spain.

Authors:  K Colom; A Fdz-Aranguiz; E Suinaga; R Cisterna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

2.  Induction potential of clavulanic acid toward L1 and L2 beta-lactamases of Stenotrophomonas maltophilia.

Authors:  C-W Lin; R-M Hu; S-C Huang; Y-J Hsiao; T-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-01       Impact factor: 3.267

3.  In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.

Authors:  M D Kitzis; B Ferré; A Coutrot; J F Acar; L Gutmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-09       Impact factor: 3.267

4.  Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid.

Authors:  P C Fuchs; R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

5.  In vitro activity of cefpodoxime, a new oral cephalosporin.

Authors:  E E Stobberingh; A W Houben; J H Philips
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-07       Impact factor: 3.267

6.  Influence of the α-Methoxy Group on the Reaction of Temocillin with Pseudomonas aeruginosa PBP3 and CTX-M-14 β-Lactamase.

Authors:  Michael D Sacco; Kyle G Kroeck; M Trent Kemp; Xiujun Zhang; Logan D Andrews; Yu Chen
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

7.  Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin.

Authors:  P D Lister; V M Gardner; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.

Authors:  S J Cavalieri; C C Sanders; C New
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

Review 9.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

10.  Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

Authors:  D A Weber; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.